These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17932974)

  • 1. Pharmacoresistant epilepsy: if at first you don't succeed..
    Shih T; Lowenstein D
    Ann Neurol; 2007 Oct; 62(4):311-3. PubMed ID: 17932974
    [No Abstract]   [Full Text] [Related]  

  • 2. Likelihood of seizure remission in an adult population with refractory epilepsy.
    Callaghan BC; Anand K; Hesdorffer D; Hauser WA; French JA
    Ann Neurol; 2007 Oct; 62(4):382-9. PubMed ID: 17880009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy.
    Cortesi M; Fusar-Poli P
    Med Hypotheses; 2007; 68(4):920-1. PubMed ID: 17112679
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country.
    Picot MC; Baldy-Moulinier M; Daurès JP; Dujols P; Crespel A
    Epilepsia; 2008 Jul; 49(7):1230-8. PubMed ID: 18363709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The definition and prediction of intractable epilepsy in children.
    Farrell K; Wirrell E; Whiting S
    Adv Neurol; 2006; 97():435-42. PubMed ID: 16383154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term pharmacotherapy of epilepsy].
    Halász P
    Orv Hetil; 2003 Dec; 144(51):2535-8. PubMed ID: 14974161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognosis in epilepsy and tactics to be applied in terminating anti-epilepsy therapy].
    Kristof M
    Psychiatr Neurol Med Psychol (Leipz); 1979 Aug; 31(8):449-57. PubMed ID: 542550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticonvulsants are often used to early].
    Reiss J
    Fortschr Med; 1997 Jun; 115(18):4, 6. PubMed ID: 9324484
    [No Abstract]   [Full Text] [Related]  

  • 9. Epilepsy treatment in developing countries: drug treatment.
    Acevedo C; Acevedo K
    Handb Clin Neurol; 2012; 108():925-41. PubMed ID: 22939076
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project.
    Ding D; Hong Z; Chen GS; Dai XY; Wu JZ; Wang WZ; De Boer HM; Sander JW; Prilipko L; Chisholm D
    Epilepsia; 2008 Mar; 49(3):535-9. PubMed ID: 18302628
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs.
    Weaver DF
    Epilepsia; 2013 May; 54 Suppl 2():56-9. PubMed ID: 23646972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-resistant epilepsy].
    Nakken KO; Taubøll E
    Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication compliance in epilepsy.
    Cramer JA
    Arch Intern Med; 1991 Jun; 151(6):1236-7. PubMed ID: 1878051
    [No Abstract]   [Full Text] [Related]  

  • 14. Epilepsy in practice.
    Kok P
    Trop Doct; 1998 Apr; 28(2):68-72. PubMed ID: 9594670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.
    Arts WF; Geerts AT
    Eur J Paediatr Neurol; 2009 Mar; 13(2):93-101. PubMed ID: 18567515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the response to antiepileptic drugs: effect of past treatment history.
    Schiller Y; Najjar Y
    Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding routine antiepileptic drug decisions: a qualitative analysis of patients' accounts of hospital consultations.
    McCorry D; Marson T; Jacoby A
    Epilepsy Behav; 2009 Jan; 14(1):210-4. PubMed ID: 18977312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s).
    Weaver DF; Pohlmann-Eden B
    Epilepsia; 2013 May; 54 Suppl 2():80-5. PubMed ID: 23646978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic aspects of cortical dysplasia in patients with pharmacoresistant epilepsies.
    Bornemann A; Schulemann H; Buchfelder M; Stefan H
    Adv Neurol; 1999; 81():323-7. PubMed ID: 10609029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcomes of surgical treatment of patients with pharmacoresistant epilepsy].
    Krylov VV; Guekht AB; Trifonov IS; Lebedeva AV; Kaimovsky IL; Sinkin MV; Grigorieva EV; Grishkina MN; Shyshkina LV; Kochetkova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):13-18. PubMed ID: 28005041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.